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Abstract
Introduction: Aspergillus, a nosocomial agent, is the most common fungal cause of suppurative thyroiditis. Most
patients with Aspergillus thyroiditis have disseminated infection, primarily with lung compromise. Late diagnosis and
treatment, severity of immunosuppressive state and thyroid hormone overload contribute to extremely high
mortality rates.
Case presentation: We describe a 20-year-old Caucasian man receiving corticosteroid suppression therapy for
systemic lupus erythematosus. He presented persistent fever with neck pain and pulmonary infection. Piperacillin/
tazobactam was initiated but after 2 days he developed hypoxemia, vascular shock, severe anemia, lymphopenia,
and high C-reactive protein. Thyroid ultrasound revealed well-defined hypoechogenic clusters in both lobes and
laboratorial thyrotoxicosis but low triiodothyronine concentration. A purulent substance was obtained on fine
needle aspiration and drained. Amphotericin B and fluconazole were added but he had unfavorable evolution and
died. Aspergillus fumigatus was defined only 2 days after his death.
Conclusions: This case serves to alert clinicians to the possibility of infectious thyroiditis and reinforces the high risk
of aspergillosis in immunocompromised patients. Therefore, management including voriconazole as first-line
treatment or amphotericin B, in association with broad-spectrum antibiotic therapy, should be adopted to improve
treatment outcome.
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Introduction
Infectious thyroiditis is relatively rare because the thy-
roid is remarkably resistant to infection due to its high
iodine content, hydrogen peroxide production, blood
supply network, abundant lymphatic drainage, and en-
capsulated location [1]. The main routes of infection in-
clude hematogenous or lymphatic spread and directly
from adjacent infected tissue. Predisposing factors in-
clude previous thyroid disease, earlier infection at distal
site, local trauma, and particularly immunocompromised
conditions, such as chemotherapy and high corticoster-
oid therapy. Suppurative or infectious thyroiditis is pain-
ful; subacute or acute etiology must be determined to
define treatment and prognosis. Local signs and symp-
toms of infection are indistinguishable among infectious
thyroiditis. Both present with painful thyroid and thyroid
enlargement, dysphagia and dysphonia. Transient thyro-
toxicosis due to the release of thyroid hormone from fol-
licular cell damage can occur. Corticosteroid therapy
masks fever.
Aspergillus, a nosocomial agent, is the most common
cause of fungal thyroiditis [2]. Most patients with fungal
thyroiditis have disseminated fungal infection, primarily
with lung compromise [2]. Delay in diagnosis and treat-
ment, severity of immunosuppressive state and thyroid
hormone overload contribute to extremely high mortal-
ity rates. We describe a patient on corticosteroid sup-
pression therapy for systemic lupus erythematosus (SLE)
diagnosed with Aspergillus thyroiditis with unfavorable
evolution to alert clinicians to this rare and severe con-
dition which is invariably overlooked.
Case presentation
A 20-year-old Caucasian man was diagnosed with SLE
due to polyarthritis, pleuritis, positive antinuclear anti-
bodies (ANA on human epithelial type 2; HEp-2), positive
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anti-double-stranded DNA, and biopsy-proven class IV
glomerulonephritis. Methylprednisolone 1g/day was started
for 3 days followed by prednisone 1mg/kg/day. After 1
month, active renal disease persisted and methylpredniso-
lone treatment was repeated. Thereafter, severe pancyto-
penia and cytomegalovirus infection were identified.
Gancyclovir was administered for 21 days with good re-
sponse. Cyclophosphamide was started (500mg) but after
1 month he presented daily fever and neck pain. At phys-
ical examination, an anterior painful cervical prominence
was observed; heart rate 122 beats per minute, tempera-
ture 37.9°C and oxygen saturation 91%. Piperacillin/tazo-
bactam was started as pulmonary infection was detected.
After 2 days, he developed hypoxemia, vascular shock, se-
vere anemia, lymphopenia (300/mm3), and high C-reactive
protein (137.5mg/L; normal range, NR, <5). Thyroid ultra-
sound revealed well-defined hypoechogenic clusters in
both lobes. Thyroid-stimulating hormone (TSH) was sup-
pressed, free thyroxine (T4) >74.6pmol/L (NR 7.7 to 18),
total T4 189pmol/dL (NR 90 to 154), total triiodothyron-
ine (T3) 1.15nmol/L (NR 1.23 to 1.85), and high serum
thyroglobulin (650.6μg/L). A purulent substance was ob-
tained on fine needle aspiration (FNA) and drained. Cyto-
logical analysis showed only pus cells. Thyrotoxicosis due
to infectious thyroiditis was established. Fungal culture of
thyroid abscess was partial positive. Amphotericin B and
fluconazole were introduced. Tracheal and blood cultures
were negative. Another thyroid ultrasound revealed per-
sistent small clusters. He underwent drainage again but no
secretion was obtained. He died at day 6 of hospital ad-
mission with suppressed TSH, lower free T4 but still high
(47.6pmol/L) and low total T3 (0.60nmol/L). A culture of
thyroid secretion took 10 days to reveal Aspergillus fumi-
gatus, identified by septate hyphae, <5μm in thickness,
with branching at acute angles, 2 days after his death.
Discussion
Painful thyroid has two main causes: subacute thyroiditis
and acute infectious thyroiditis [3]. Subacute thyroiditis
is by far the most common cause of thyroid pain. Never-
theless, acute infectious thyroiditis or suppurative thy-
roiditis is a potentially life-threatening condition. As
pain is the common presentation, clinical pictures can
be used for differential diagnosis. Subacute thyroiditis
frequently manifests with three classical phases: transi-
ent thyrotoxicosis, followed by transient hypothyroidism
and usually euthyroidism. Patients report previous viral
infection with low fever and malaise. Therapy aims to
relieve pain; evolution is favorable and self-limited. Sub-
acute thyroiditis rarely causes severe thyrotoxicosis [1].
Conversely, infectious acute thyroiditis is a potentially
life-threatening disorder whose prognosis depends on
prompt recognition and treatment [4]. Bacterial, fungal,
and even parasitic organisms have been documented as
etiologic agents. Phlogistic signs are often seen. Abscess
drainage and antimicrobial therapy, including antifungal,
must be performed. In contrast to subacute thyroiditis,
thyroid dysfunction is rarely noted in this condition.
Of interest, our case showed all the classical signs and
symptoms of subacute thyroiditis and had a previous
cytomegalovirus infection. However, he was already on
corticosteroid therapy which is effective to treat sub-
acute thyroiditis. Immunocompromised status that oc-
curs in patients with human immunodeficiency virus,
corticosteroid therapy, organ transplant and chemother-
apy, is prone to atypical infections, rare etiologies, bi-
zarre presentations and unusual primary infectious foci.
Common pathogens are encountered with greater fre-
quency in a dose-dependent manner during therapy with
glucocorticoids. Most patients present viral infections,
herpes or cytomegalovirus, as our patient, but may also
have Staphylococcus, candidiasis and Strongyloides. Asper-
gillus is increasingly recognized as an important nosoco-
mial pathogen in immunocompromised patients but it is
difficult to diagnose antemortem and typically has a fatal
outcome. At autopsy, thyroid commitment is the result of
a disseminated infection even in the absence of thyroid
dysfunction [5]. Antemortem diagnosis is reached by dir-
ect microscopy and culture after FNA or by biopsy in
most reported cases. Thyroid FNA is the easiest and fast-
est method of diagnosis, and cytological analysis reveals
profuse purulent infiltration with hypha. In this regard,
aerobic and anaerobic cultures of FNA specimens must
also be performed, but fungal cultures are also mandatory.
Unfortunately, fungal culture involves a lengthy process.
Therefore, our management included broad-spectrum an-
tibiotics and metronidazole. Amphotericin B and flucona-
zole however, were only added after positive fungal culture
and, albeit unsuccessful, abscess drainage. Thyroidectomy
should be performed only to debride necrotic tissue and
to remove infected tissue if abscess persists. Surgery has
more death risk as it requires a patient in better condition
to tolerate surgery, as bleeding and hemodynamic instabil-
ity are common.
Our service does not provide voriconazole, the best
treatment to Aspergillus infection [6]. Some authors sug-
gest that fluconazole should be added to treatment for im-
munocompromised infected patients, as well as Aspergillus
serology [2]. As the primary site is frequently located in
the upper respiratory tract, nasal or orotracheal samples
must be collected for repetitive fungal culture, especially
with mild lung infiltration. Growth of Aspergillus in blood
cultures is rare but highly specific [7]. It is noteworthy that
fungal cultures from orotracheal secretion and blood were
negative in our patient. In our patient, fungal cultures took
10 days to reveal Aspergillus in colonies.
All but one anecdotal case of Aspergillus thyroiditis
reported previously had unfavorable outcomes, which
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suggest delays in diagnosis, representing a marker of poor
prognosis [2,8-11].
Also of interest, our patient presented low T3 concomi-
tant with high T4 level. After follicular thyroid damage, T4
is disproportionately elevated relative to T3, reflecting
intrathyroidal T4/T3 ratio. Conversely, low T3 observed in
our patient could also reflect worse prognosis, as identified
in euthyroid sick syndrome [12].
Conclusions
This case alerts clinicians to the possibility of infectious
thyroiditis and reinforces the high risk of aspergillosis in
immunocompromised patients. Therefore, management
including voriconazole and amphotericin B, in associ-
ation with broad-spectrum antibiotic therapy, should be
adopted to improve treatment outcome.
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